This funding opportunity supports Stage 2 of the Somatic Mosaicism across Human Tissues (SMaHT) Genome Characterization Centers initiative. It focuses on determining the functional consequences of somatic mutations in healthy and clinically relevant human tissue samples, advancing the understanding of somatic mosaicism's role in human biology and disease through multi-omic data analysis.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and certain non-U.S. entities. Specific eligibility details are extensive and include various government levels and organizational types.
